Ectopic overexpression of miR-572 promoted ovarian cancer cell proliferation and cell cycle progression in vitro and tumorigenicity in vivo by inhibiting its direct target suppressor of cytokine signaling 1 and cyclin-dependent kinase inhibitor 1A (p21KIP). Here, CDKN1A is linked to ovarian cancer.